Medical publishing house PMPH-USA has announced the publication of Hepatobiliary Cancer edited by Yuman Fong of Sloan Kettering Cancer Center and Jia-hong Dong of the Chinese PLA General Hospital in Beijing, China, both internationally recognized for their research and expertise in liver and biliary surgery. Section editors are Ghassan Abou-Alfa and Gary E. Deng of Memorial Sloan Kettering Cancer Center and Dr. Damian Dupuy of the Warren Alpert Medical School at Brown University.
With the technological advances in imaging and therapy over the past two decades, hepatobiliary cancer no longer carries a prognosis of certain death. This concise yet comprehensive text reflects the most current approaches and technology used at major cancer treatment facilities around the world in the management of liver and biliary cancers. It is an international collaboration of world authorities in the areas of surgery, chemotherapy, radiation therapy, medical oncology, and integrative medicine. Chapters summarise the state-of-the-art therapies with algorithms of care and potential directions for future evolution. It is beautifully illustrated with numerous tables and colour surgical and radiographic images.
Authors of the 24 chapters are affiliated with major cancer centers around the globe including Memorial Sloan Kettering Cancer Center in New York, PLA Hospital in Beijing, Fudan University Shanghai Cancer Center and The University of Hong Kong (China), University of Heidelberg (Germany), University of Liverpool and University of Birmingham (UK), University of Tokyo and Research Center for Innovative Oncology (Japan), and Sanjay Gandhi Institute (India). Other US affiliations include Columbia University, Fineberg School of Medicine at Northwestern University,Warren Alpert Medical School of Brown University, Johns Hopkins Hospital, the Mayo Clinic, David Geffen School of Medicine at UCLA, University of Medicine and Dentistry of New Jersey, and Florida International University College of Medicine.
Dr. Yuman Fong is Murray F. Brennan Chair in Surgery and Co-Director of Center for Image-guided Interventions at Memorial Sloan-Kettering Cancer Center and Professor of Surgery at Weill Cornell Medical College. He is well-known internationally for his research and pioneering work in developing minimally invasive surgery and ablative therapies for hepatobiliary cancer. He has co-authored over 500 peer-reviewed articles and served on editorial boards of 14 journals. He currently serves as Chair of the recombinant DNA advisory committee of the National Institutes of Health.
Dr. Jia-Hong Dong is Professor and Chairman, Hospital & Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Chinese PLA Medical Postgraduate School, Beijing, China.
